Envestnet Asset Management Inc. Has $231.99 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Envestnet Asset Management Inc. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 518,719 shares of the medical equipment provider’s stock after selling 21,105 shares during the period. Envestnet Asset Management Inc. owned 0.14% of Intuitive Surgical worth $231,987,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in ISRG. Brighton Jones LLC lifted its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Sivia Capital Partners LLC increased its stake in Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares in the last quarter. BankPlus Trust Department raised its holdings in shares of Intuitive Surgical by 131.8% during the second quarter. BankPlus Trust Department now owns 153 shares of the medical equipment provider’s stock valued at $83,000 after purchasing an additional 87 shares during the period. Venturi Wealth Management LLC raised its holdings in shares of Intuitive Surgical by 4.6% during the second quarter. Venturi Wealth Management LLC now owns 1,795 shares of the medical equipment provider’s stock valued at $975,000 after purchasing an additional 79 shares during the period. Finally, Sax Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 218.1% during the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock worth $1,334,000 after purchasing an additional 1,684 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

ISRG opened at $476.32 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The company has a market capitalization of $170.75 billion, a price-to-earnings ratio of 60.37, a P/E/G ratio of 3.71 and a beta of 1.65. The firm’s fifty day moving average price is $551.33 and its two-hundred day moving average price is $510.73.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period last year, the firm earned $2.21 earnings per share. The firm’s revenue was up 18.8% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research analyst reports. Argus dropped their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Sanford C. Bernstein increased their target price on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Daiwa Capital Markets lifted their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Finally, HSBC upped their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $617.23.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the transaction, the senior vice president owned 907 shares in the company, valued at $496,455.52. This represents a 83.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the sale, the director owned 3,694 shares in the company, valued at $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 73,616 shares of company stock worth $40,929,575. 0.70% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.